SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Share Price
Equities
600196
CNE000000X38
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.17 CNY | -0.70% |
|
+2.11% | -3.44% |
| 05-10 | Fosun Pharma Unit Gets China Marketing Approval for Schizophrenia Tablets | MT |
| 05-09 | Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug | MT |
| Sales 2024 * | 44.43B 6.15B 491B | Sales 2025 * | 50.5B 6.99B 558B | Capitalization | 58.07B 8.04B 642B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.14B 435M 34.72B | Net income 2025 * | 4.12B 571M 45.6B | EV / Sales 2024 * | 1.66 x |
| Net Debt 2024 * | 15.46B 2.14B 171B | Net Debt 2025 * | 17.72B 2.45B 196B | EV / Sales 2025 * | 1.5 x |
| P/E ratio 2024 * |
20.4
x | P/E ratio 2025 * |
15.5
x | Employees | 40,370 |
| Yield 2024 * |
1.55% | Yield 2025 * |
1.99% | Free-Float | 63.46% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.70% | ||
| 1 week | +2.11% | ||
| Current month | +2.11% | ||
| 1 month | +5.36% | ||
| 3 months | +0.92% | ||
| 6 months | -14.83% | ||
| Current year | -3.44% |
1 week
23.82
24.62
1 month
22.2524.62
Current year
20.3825.89
1 year
20.3832.73
3 years
20.3891.69
5 years
20.3891.69
10 years
16.5091.69
| Managers | Title | Age | Since |
|---|---|---|---|
De Yong Wen
CEO | Chief Executive Officer | 52 | - |
Dong Ming Li
PSD | President | 55 | 28/10/20 |
Yi Fang Wu
CHM | Chairman | 54 | 31/03/04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 08/04/10 |
Qi Yu Chen
BRD | Director/Board Member | 52 | 31/03/94 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.27% | 0 M€ | -12.22% | - | |
| 1.18% | 4 M€ | -2.96% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 24.17 | -0.70% | 9,038,491 |
| 09/05/24 | 24.34 | +0.70% | 12,861,240 |
| 08/05/24 | 24.17 | -0.08% | 13,420,440 |
| 07/05/24 | 24.19 | +0.29% | 10,573,420 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotes
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
25/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
24.17
CNY
Average target price
28.61
CNY
Spread / Average Target
+18.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.44% | 8.04B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 600196 Stock
